Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?

被引：1
|
作者：
Del Buono, Marco G. [1 ,2 ]
Damonte, Juan, I [1 ,3 ]
Trankle, Cory R. [1 ]
Bhardwaj, Hem [1 ]
Markley, Roshanak [1 ]
Turlington, Jeremy [1 ]
Van Tassell, Benjamin W. [1 ,4 ]
Salloum, Fadi N. [1 ]
Abbate, Antonio [1 ]
机构：
[1] Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, Dept Internal Med, Richmond, VA 23298 USA
[2] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Thorac Sci, Rome, Italy
[3] Hosp Italiano Buenos Aires, Dept Hemodynam & Intervent Cardiol, Buenos Aires, DF, Argentina
[4] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA 23298 USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2021年 / 78卷 / 03期
关键词：
ACUTE MYOCARDIAL-INFARCTION; CLINICAL-EVIDENCE; MORTALITY; MORBIDITY; SURVIVORS; RAMIPRIL;
D O I：
10.1097/FJC.0000000000001103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：331 / 333
页数：3
相关论文
共 50 条
  • [11] New Innovations in Treatment and Monitoring of Heart Failure With Guidelines on the Use of Sacubitril/Valsartan and Ivabradine
    Thampi, Shankar
    Sheth, Shikha
    Madu, Chinedu
    Chionchio, Alicia
    Loukas, Evangelos
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (01) : E92 - E103
  • [12] The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update
    Nielsen, Peter Munch
    Grimm, Daniela
    Wehland, Markus
    Simonsen, Ulf
    Krueger, Marcus
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 9 - 18
  • [13] Sacubitril/valsartan (LCZ696) for the treatment of heart failure
    Gori, Mauro
    Senni, Michele
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (02) : 145 - 153
  • [14] Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?
    Del Buono, Marco Giuseppe
    Bonaventura, Aldo
    Vecchie, Alessandra
    Wohlford, George F.
    Dixon, Dave L.
    Van Tassel, Benjamin W.
    Abbate, Antonio
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (02) : 105 - 107
  • [15] The safety of sacubitril-valsartan for the treatment of chronic heart failure
    Tyler, Jeffrey M.
    Teerlink, John R.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 257 - 263
  • [16] Sacubitril-Valsartan for the Treatment of Heart Failure Effectiveness and Value
    Ollendorf, Daniel A.
    Sandhu, Alexander T.
    Pearson, Steven D.
    JAMA INTERNAL MEDICINE, 2016, 176 (02) : 249 - 250
  • [17] The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
    Jhund, Pardeep S.
    McMurray, John J. V.
    HEART, 2016, 102 (17) : 1342 - 1347
  • [18] USE OF VALSARTAN-SACUBITRIL IN ELIGIBLE SYSTOLIC HEART FAILURE PATIENTS
    Dhamija, Yashu
    Kaelber, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 765 - 765
  • [19] Use of sacubitril/valsartan in acute decompensated heart failure: a case report
    Bell, Taison D.
    Mazer, Adrien J.
    Miller, P. Elliott
    Strich, Jeffrey R.
    Sachdev, Vandana
    Wright, Mary E.
    Solomon, Michael A.
    ESC HEART FAILURE, 2018, 5 (01): : 184 - 188
  • [20] Heart failure features and sacubitril/valsartan effects
    Malfatto, Gabriella
    Villani, Alessandra
    Parati, Gianfranco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 234 - 235
12345